Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
AVAMYS Nasenspray 27.5 mcg/Dosis 120 Dos
Drug
Avamys, Nasenspray, Suspension
Rhinitis
12.02.3. – nasal drugs with corticosteroids
HAM – Human medicine
NASSS – nasal spray, suspension
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
12/19/2007
12/31/9999
Dosage strength
Avamys, Nasenspray, Suspension
Rhinitis
01
Z – approved
Package
7680579680051
In trade from / since 12/19/2007
A/R – Authorised / referenced
120 Single-dose(s)
005
Z – approved
Declaration
Component
27.5 µg fluticasoni furoas
glucosum
cellulosum dispergibile
polysorbatum 80
dinatrii edetas
8.25 µg benzalkonii chloridum
aqua purificata
cellulosum dispergibile
polysorbatum 80
dinatrii edetas
8.25 µg benzalkonii chloridum
aqua purificata
Spezialitätenliste***
SL
-
-
16.60
None
No
10%
No
Authorisation holder
7601001000674
GlaxoSmithKline AG
Neuhofstrasse 4
6340 Baar (ZG)
Neuhofstrasse 4
6340 Baar (ZG)
Date of revision of the text
12/4/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.